Rowatinex, 30 capsules, Rowa Wagner

Rowatinex, 30 capsules, Rowa Wagner

Prophylaxis and treatment of urinary lithiasis.

Adjuvant in the treatment of mild-moderate urinary infections and nephropathies.

Pharmacotherapeutic group: other urological products, urinary antispasmodics.

Composition:

A gastro-resistant soft capsule contains alpha-pinene 24.8 mg, beta-pinene 6.2 mg, camphene 15 mg, cineole 3 mg, fencone 4 mg, borneol 10 mg, anethole 4 mg and excipients: capsule content - olive oil, capsule - gelatin, glycerol 85%, sodium ethyl hydroxybenzoate, sodium propyl hydroxybenzoate, (E217), Sunset yellow FCF (E110), quinoline yellow (E104).

How to use:

• Adults: the usual dose is one Rowatinex capsule 3-4 times a day, 30 minutes before meals or as recommended by the doctor
• Children aged between 6 and 14 years: the usual dose is one Rowatinex capsule 1-2 times a day, 30 minutes before meals or as recommended by the doctor
• At the doctor's recommendation, during very painful periods, especially if colic pains occur, a dose of 20-30 oral drops of Rowatinex solution is administered, which can be repeated after 15-20 minutes if necessary or administered up to 40 oral drops, Rowatinex solution in a single dose
• Children aged between 6 and 14 years. The usual dose is 1-2 oral drops of Rowatinex solution 3-4 times a day, 30 minutes before meals or according to the doctor's recommendation.

Adverse reactions:

• Occasionally, mild and transient gastric disturbances have been reported
• Rarely, vomiting has been reported
• Two mild cases of drug intolerance were reported
• Allergic reactions may occur, even delayed ones (see Precautions).

Overdose:

• In case of overdose, gastric irritation with nausea, vomiting and diarrhea may occur
• If the medicine was swallowed a short time ago, gastric lavage will be performed
• The patient must be carefully monitored and, if necessary, symptomatic treatment will be instituted. Cardiac, respiratory, renal and hepatic function must be monitored
• Toxicological studies in animals have shown that large doses of essential oils can cause depression of the central nervous system with stupor and respiratory failure or stimulation of the central nervous system to the point of excitement and convulsions.

Contraindications:

Severe renal colic, anuria, serious urinary tract infections, urinary lithiasis requiring surgical treatment.

Precautions:

• Because the capsules contain Sunset yellow FCF (E110), allergic reactions may occur
• Due to the content of p-hydroxybenzoate esters in the capsule, Rowatinex capsules can cause allergic reactions (even delayed).

Interactions:

Precautions should be considered in patients treated with anticoagulants or other drugs metabolized by the liver that have a low therapeutic index.

Warnings:

• In patients with renal colic, medical supervision of the treatment is recommended
• Pregnancy and breast-feeding: although no teratogenic effects have been reported, Rowatinex should not be administered during the first trimester of pregnancy. As sufficient information is not available, Rowatinex should not be administered to women who are breast-feeding
• Ability to drive vehicles or use machines: Rowatinex does not influence the ability to drive vehicles or use machines
• Do not use after the expiration date written on the package
• To be kept at temperatures below 25 C, in the original packaging
• Keep out of reach of children.

Presentation: 30 capsules